Amador Bioscience is a Translational & Clinical CRO providing quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to biopharmaceutical companies in China, USA and EU.
Amador facilitates innovative drug development from discovery to clinical development and global regulatory filings. Our clients range from cutting-edge biotech startups to industry-leading multinationals.